This powerpoint presentation begins by providing a brief overview of the critical issues with bromate, with the major question being whether the doses at which bromate enters target
tissues are at effective concentrations. The data needs for developing a
physiologically-based
pharmacokinetic model for bromate are presented, along with extensive conclusions and implications for risk assessment. Includes tables, figures.